Russell Investments Group
TPST icon

Russell Investments Group’s Tempest Therapeutics TPST Stock Holding History

Russell Investments Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-77
Closed -$26K – 3256
2020
Q2 		$26K Buy
+77
New +$30.7K ﹤0.01% 3037
2018
Q2 		– Sell
-9
Closed -$22K – 2958
2018
Q1 		$22K Hold
9
– – ﹤0.01% 2873
2017
Q4 		$39K Buy
+9
New +$37.8K ﹤0.01% 2891
2017
Q2 		– Sell
-2
Closed -$11K – 3034
2017
Q1 		$11K Hold
2
– – ﹤0.01% 2970
2016
Q4 		$10K Buy
+2
New +$24.9K ﹤0.01% 3054

Other funds holding TPST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Russell Investments Group's TPST Position: Q3 2020 in Review

Russell Investments Group sold out of Tempest Therapeutics (TPST) in Q3 2020, closing a stake of 77 shares — an estimated $26K sold.

Russell Investments Group first reported a position in TPST in Q4 2016 and held it in 5 quarters. The position peaked at $39K in Q4 2017. 42 funds tracked by Wall St. Rank hold TPST as of Q3 2020.

  • Russell Investments Group reported no remaining Tempest Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Russell Investments Group sold 77 Tempest Therapeutics shares in Q3 2020, an estimated $26K.
  • Russell Investments Group first reported a position in Tempest Therapeutics in Q4 2016 and held it in 5 quarters.
  • Russell Investments Group's Tempest Therapeutics position peaked at $39K in Q4 2017.
  • 42 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2020.

Based on Russell Investments Group's 13F filing for Q3 2020, filed 9 Nov 2020.